To further explore whether the miR-663a/TGF-β/Smad pathway is associated with the effects of GA on hepatic fibrosis, miR-663a expression and the TGF-β/Smad signaling pathway-related protein levels were detected in vitro after GA treatment. The gene discussed is TGFB1; the disease is Hepatic fibrosis.